Predictive and prognostic value of ZEB1 protein expression in breast cancer patients with neoadjuvant chemotherapy

被引：0
|
作者：
Ziping Wu
Lei Zhang
Shuguang Xu
Yanping Lin
Wenjin Yin
Jinglu Lu
Rui Sha
Xiaonan Sheng
Liheng Zhou
Jinsong Lu
机构：
[1] Shanghai Jiao Tong University,Department of Breast Surgery, Renji Hospital, School of Medicine
来源：
Cancer Cell International | / 19卷
关键词：
Breast cancer; Neoadjuvant chemotherapy; ZEB1; Predictive; Prognostic;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Prognostic value of HMGB1 in early breast cancer patients under neoadjuvant chemotherapy
    Exner, Ruth
    Sachet, Monika
    Arnold, Tobias
    Zinn-Zinnenburg, Mercedes
    Michlmayr, Anna
    Dubsky, Peter
    Bartsch, Rupert
    Steger, Guenther
    Gnant, Michael
    Bergmann, Michael
    Bachleitner-Hofmann, Thomas
    Oehler, Rudolf
    CANCER MEDICINE, 2016, 5 (09): : 2350 - 2358
  • [22] Predictive value of microenvironment for progression in breast cancer patients treated with neoadjuvant chemotherapy
    Goto, Wataru
    Kashiwagi, Shinichiro
    Asano, Yuka
    Takada, Koji
    Takahashi, Katsuyuki
    Noda, Satoru
    Takashima, Tsutomu
    Onoda, Naoyoshi
    Tomita, Shuhei
    Hirakawa, Kosei
    Ohira, Masaichi
    CANCER SCIENCE, 2018, 109 : 123 - 123
  • [23] Prognostic value of persistent node involvement after neoadjuvant chemotherapy in patients with operable breast cancer
    Pierga, JY
    Mouret, E
    Diéras, V
    Laurence, V
    Beuzeboc, P
    Dorval, T
    Palangié, T
    Jouve, M
    Vincent-Salomon, A
    Scholl, S
    Extra, JM
    Asselain, B
    Pouillart, P
    BRITISH JOURNAL OF CANCER, 2000, 83 (11) : 1480 - 1487
  • [24] Prognostic value of persistent node involvement after neoadjuvant chemotherapy in patients with operable breast cancer
    J-Y Pierga
    E Mouret
    V Diéras
    V Laurence
    P Beuzeboc
    T Dorval
    T Palangié
    M Jouve
    A Vincent-Salomon
    S Scholl
    J-M Extra
    B Asselain
    P Pouillart
    British Journal of Cancer, 2000, 83 : 1480 - 1487
  • [25] Prognostic factors in breast cancer patients following neoadjuvant chemotherapy
    Kim, JR
    Chang, ES
    BIOMEDICINE & PHARMACOTHERAPY, 2005, 59 : S395 - S396
  • [26] Clinical significance and prognostic value of receptor conversion after neoadjuvant chemotherapy in breast cancer patients
    He, Yang
    Zhang, Jing
    Chen, Hui
    Zhou, Ying
    Hong, Liping
    Ma, Yue
    Chen, Nannan
    Zhao, Weipeng
    Tong, Zhongsheng
    FRONTIERS IN SURGERY, 2023, 9
  • [27] Inflammatory Blood Markers as Prognostic and Predictive Factors in Early Breast Cancer Patients Receiving Neoadjuvant Chemotherapy
    Corbeau, Ileana
    Thezenas, Simon
    Maran-Gonzalez, Aurelie
    Colombo, Pierre-Emmanuel
    Jacot, William
    Guiu, Severine
    CANCERS, 2020, 12 (09) : 1 - 16
  • [28] The prognostic value of histological grade determined after neoadjuvant chemotherapy of breast cancer
    Zombori, Tamas
    Ferenczi, Adam
    Sejben, Anita
    Almasi, Szintia
    Szelestei, Veronika
    Koszo, Renata
    Lantos, Tamas
    Kahan, Zsuzsanna
    Cserni, Gabor
    PATHOLOGY RESEARCH AND PRACTICE, 2025, 265 : 155732
  • [29] Mammographic breast density: Predictive value for pathological response to neoadjuvant chemotherapy in breast cancer patients
    Elsamany, S.
    Alzahrani, A.
    Abozeed, W. N.
    Rasmy, A.
    Farooq, M. U.
    Elbiomy, M. A.
    Rawah, E.
    Alsaleh, K.
    Abdel-Aziz, N. M.
    BREAST, 2015, 24 (05) : 576 - 581
  • [30] Prognostic value of Bcl-2 in breast cancer patients treated with neoadjuvant anthracycline based chemotherapy
    Vargas-Roig, Laura M.
    Cuello-Carrion, F. Dario
    Fernandez-Escobar, Nicolas
    Daguerre, Pedro
    Leuzzi, Marcela
    Ibarra, Jorge
    Gago, Francisco E.
    Nadin, Silvina B.
    Ciocca, Daniel R.
    MOLECULAR ONCOLOGY, 2008, 2 (01) : 102 - 111
12345